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The ethics of personal advertising in surgery
James W. Jones, MD, PhD, MHA,a Laurence B. McCullough, PhD,a and Bruce W. Richman, MA,bHouston, Tex; and Columbia, MoReputation is an idle and most false imposition; oft got
without merit and lost without deserving. William Shake-
speare (Othello 2.3.266-268)
As a pioneer in endoluminal stent-graft placement,
you are clearly the leading practitioner of endovascular
procedures in your metropolitan area and, perhaps, the
world. You therefore find yourself appalled by the
radio, television, and newspaper advertising campaign
of Fluff General, a cross-town hospital, claiming that
its endovascular surgery program has the most exten-
sive experience and the best record of patient outcomes
and satisfaction for these procedures in the community.
You approach your hospital’s marketing office about
running a comparable advertising campaign rebutting
the false claims of Fluff, but are told that the advertis-
ing budget has been depleted by efforts to promote a
new cancer center. What is your most ethically sound
course of action?
A. Contact the American Medical Association (AMA) to
report your competitor’s violation of the AMA prohibi-
tion on physician advertising.
B. Engage an advertising agency at your own expense and
direct them to emphasize your superior expertise by
interviewing patients with good outcomes.
C. Sue the other hospital for false advertising.
D. On the premise that personal advertising is too ethically
risky to be permissible, write a letter to the competing
hospital’s Board of Directors, asking them to stop their
ad campaign.
E. File a complaint with the College of Surgeons against
the competing hospital.
Reputation is a critical variable in a specialty heavily
dependent upon referrals by colleagues in other fields of
medicine. The physician has traditionally built a reputation
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doi:10.1016/j.jvs.2004.05.002by (1) his or her recognition as an expert in a specialty or
procedure through publication, peer interaction, and ten-
ure in the field; (2) his or her association with respected
institutions like prestigious hospitals and clinics, research
and training centers, and selective professional organiza-
tions; and (3) the testimonials of satisfied patients. Com-
mercial advertising, until recently shunned by reputable
members of the medical profession as beneath their dignity,
tries an end-run around these venerable and legitimate
methods of establishing legitimacy and attracting referrals.
Physicians—not hospitals, not advertising campaigns,
and certainly not entertaining turns of phrase—determine
the quality of patient care, and physicians everywhere have
a right to indignation when they find themselves excluded
from their affiliated institutions’ marketing plan, or when
they encounter false and misleading medical claims by
other institutions.1 In this case, the vascular surgeons at the
competing hospital probably did not draft the offensive
advertising campaign or even contribute their advice. The
marketing specialists who did cared little for statistical
comparisons of caseload, morbidity and mortality rates, and
long-term follow-up before making inflated claims accom-
panied by bouncy music, four color graphics, and photos of
smiling, attractive, and fashionably dressed people enjoying
active lives. These seemingly benign representations are
nonetheless ethically reprehensible because they claim for
the hospital’s endovascular program a pre-eminence to
which it is not entitled, by implication diminishing the
hard-won reputation of the local surgeon who is actually
entitled to this recognition and violating fiduciary respon-
sibility by guiding patients away from a superior source of
care for the sake of self-enrichment.
No one can realistically expect the second hospital to
close down its endovascular surgical program simply be-
cause there may be a better one in town, but the right to
remain open confers no entitlement to use misleading
suggestions and frank deceptions to misrepresent itself and
its competitor. The hospital may legitimately improve its
marketing position by making the investments necessary to
bring its program into alignment with the quality available
at your hospital. However, its claims must remain limited to
what it can actually demonstrate; it cannot extend this
license beyond the limits of the truth.397
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which commercial advertising thrives, words like “best,”
“leading,” “most,” and “outstanding” defy quantification
and even definition, particularly in places like courts of law,
where variabilities in the meaning of words are often deci-
sive factors in the assignment of culpability. Although it is
clear to you that the advertising claims of the competing
hospital are patently false, they are unlikely to meet that
standard in a law court, where their imprecision and sub-
jectivity will provide sufficient shield against accusations of
deceptive intent. Option C is therefore an expensive and
likely futile exercise.
Option B would attempt to counter the competing
hospital’s false advertising with advertising funded by the
offended surgeon. The idea has some appeal, as an accurate,
evidence-based public information campaign could serve as
an important contribution to the public’s understanding of
your work. Personal advertising of specific procedures com-
monly self-referred, optional for physical health, and likely
to be self-paid, is commonplace among ophthalmologists,
fertility experts, and cosmetic surgeons. Even so, it is rare
for these surgeon advertisers to depart into advertising
operations that usually require physician-to-physician refer-
rals to treat diseases. Assuming that personal advertising
can indeed be balanced and not deceptive, does it have a
place in ethical surgical practice?
Advertising is a “call for public attention by arousing
the desire to buy or to patronize.”2 Thus understood, the
practice involves a consciously self-serving effort to pro-
mote revenues by arranging the style, content, and presen-
tation of information to solicit the patronage of potential
consumers. All medical advertising, personal as well as
institutional, necessarily reduces medical care to a commer-
cial commodity. Medicine would suffer greatly should that
transformation ever be completed.
Surgeons must understand that advertising their ser-
vices violates the integrity of the time-tested professional
referral system. Candidates for surgical care have tradition-
ally been carefully evaluated by non-surgeons, tried on a
conservative treatment regimen when indicated, and re-
ferred to the appropriate surgical specialist only when test
results have been completed, and usually when less invasive
therapeutic trials have failed. Relying heavily upon the
venerable bases of professional reputation, the internist or
other referring physician selects a surgeon who he has good
reason to believe is well-suited to perform the indicated
procedure or to honestly decide on nonoperative therapy,
and to understand precisely which procedure would best
restore the patient’s health. Though the referral process
does not always function with uniform perfection, the chain
of referral imparts essential patient protections. These in-
clude shared fiduciary responsibility between the physi-
cians; collaborative consideration of the disease process
between at least 2 professionals with specialized knowledge
of the patient’s condition; informed review of indications
and contraindications for the surgical procedure; and the
selection of an appropriately capable and experienced sur-
geon, an especially important consideration when the pro-posed operation is of special complexity, high difficulty, or
high risk, or is rarely performed.
Advertisers have no fiduciary responsibility; they are
lightly constrained only by a legal prohibition against
grossly false claims, the limits of which constraint they
challenge every time they display unpleasant truths in mi-
croscopic print or use ambiguous terminology. Even when
the practice of commercial advertising is not demonstrably
unethical, it is by its nature “nonethical”—ethical ques-
tions are simply not asked by its practitioners. Like the
attorney advocate, the advertiser’s purpose is to plasticize
the truth.
Rutherford3 was almost preternaturally prescient in
predicting shortly after its introduction that endovascular
surgery would be plagued by unethical advertising and
self-serving reporting practices. Advertising and medicine
are an inherently bad fit because the primary goal of adver-
tising is the advancement of individual self-interest without
consideration of consequences inflicted upon either com-
petitors or clientele. This is at perfect odds with the fidu-
ciary responsibility, which distinguishes the medical profes-
sion from virtually every other form of human endeavor in
which money is exchanged for service.4 Pellegrino5 has
compared physician advertising to “Faustian moral com-
pacts with business,” and has encouraged physicians to
avoid participation. Option B, battling the evils of the
marketplace with its own instruments, compromises your
own ethical standards by dipping you in the same raw
sewage that has so badly offended you. It is, therefore, not
an acceptable choice.
Unfortunately, Option A is no longer a viable course
because the AMA Committee on Ethics and Policy has
changed its position and now acknowledges doctors’ right
to advertise. It did not happily do so; a court ruling forced
the Association to renounce its ban on advertising in 1975.
The AMA continues to insist, however, that “the key issue
is whether advertising or publicity, regardless of format or
context, is true and not materially misleading.6 We hope to
convince the reader that neither the courts nor respected
professional organizations maintain an ethically correct
stance on the matter of personal advertising.
Truth can be elusive, however, and it can be eluded as
well when advertisers eschew the admittedly dry statistical
comparisons the medical profession routinely relies upon in
our books and journals to demonstrate one group’s supe-
riority over another in resolving carefully delineated prob-
lems, replacing these comparisons with images of attractive
young women, sloops under sail at sunset, and laughing,
energetic people. The objective correlative may make no
overt claim, but it subtly leads patients away from realistic
consideration of morbidity, mortality, pain, incomplete
cures, and botched operations, and toward a belief that they
need operations that they don’t need.7
The American College of Surgeons has been one of the
most venerable advocates of ethical principles in the medi-
cal profession, but recognizes no obligation by its members
to correct the ethical lapses of the hospitals in which they
practice. The advertising campaign at issue here was initi-
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the surgeons whose increased caseload is entirely second-
ary. Until the College and other prestigious professional
organizations like it encourage their specialist membership
to insist that their host institutions uphold the same ethical
principles to which they subscribe professionally, Option E
will not be an effective response.
Although allowed by law and professional organiza-
tions, personal surgical advertising that disrupts traditional
professional referrals is ethically too risky to be permissible,
making Option D the most ethical action. A personal letter
of objection to the competitor’s Board of Directors may
specifically cite data reflective of your superior clinical ex-
perience, your research and publication history, and your
groundbreaking work in endovascular surgery. A polite,
well-reasoned explanation of your objections to statements
that mislead the public, mischaracterize their program, and
misrepresent your own as inferior is quite likely to become
the subject of intense discussion at the next meeting of the
Board. Writing such a letter requires no financial outlay, or
even approval, by the hospital at which you now operate,and does not obligate you to abandon your own personal
and ethical values by answering your antagonists in kind.
Confronted in this manner, the offending group may well
be made aware, perhaps for the first time, of the ethical
implications of its commercial advertising program, and
understand its obligation to realign it to closer conformity
with the ethical norms of the medical profession.
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